Last reviewed · How we verify

NCT05806528

Role of Placental Invasion Index in Decision Making of Placenta Accreta

Status unknown Last updated 10 April 2023
What this trial tests

trial testing Ultrasound in Placenta Accreta in 100 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
1 January 2024
1 March 2024

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 April 2023
Primary completion1 January 2024
Estimated completion1 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Eligibility, female only, with Placenta Accreta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted on women who have a diagnosis of placenta previ and using ultrasound to make the placenta invasion index and compare the accuracy of the diagnosis during the caesarean section whether it is accreta or not with determining the site and depth of invasion

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Placenta Accreta

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05806528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing